Lipocine Consolidated Income vs Research and Development Expense Analysis

LPCN Stock  USD 5.13  0.12  2.40%   
Trend analysis of Lipocine balance sheet accounts such as Total Stockholder Equity of 24.6 M provides information on Lipocine's total assets, liabilities, and equity, which is the actual value of Lipocine to its prevalent stockholders. By breaking down trends over time using Lipocine balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

About Lipocine Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lipocine at a specified time, usually calculated after every quarter, six months, or one year. Lipocine Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lipocine and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lipocine currently owns. An asset can also be divided into two categories, current and non-current.

Lipocine Balance Sheet Chart

Lipocine Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Lipocine uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Lipocine's Cash And Short Term Investments are very stable compared to the past year. As of the 28th of March 2024, Common Stock Total Equity is likely to grow to about 10.7 K, while Other Liabilities is likely to drop about 196.5 K.

Total Assets

Total assets refers to the total amount of Lipocine assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lipocine books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Lipocine balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lipocine are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Lipocine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.As of the 28th of March 2024, Selling General Administrative is likely to grow to about 5.8 M, while Tax Provision is likely to drop 411.40.
 2021 2022 2023 2024 (projected)
Total Operating Expenses5.3M4.1M15.1M15.8M
Cost Of Revenue7.7M8.6M28.7K27.2K

Lipocine fundamental ratios Correlations

0.320.440.96-0.28-0.5-0.540.540.510.40.990.430.250.160.690.21.00.46-0.080.91-0.580.660.66-0.540.210.54
0.320.580.27-0.02-0.04-0.310.130.0-0.020.310.08-0.01-0.110.340.190.340.090.170.26-0.340.360.33-0.510.33-0.03
0.440.580.22-0.230.1-0.70.720.040.140.330.42-0.10.340.690.850.440.45-0.460.2-0.770.340.66-0.71-0.260.22
0.960.270.22-0.26-0.56-0.390.380.520.410.990.360.290.010.56-0.070.960.390.080.95-0.410.650.54-0.390.340.54
-0.28-0.02-0.23-0.26-0.140.61-0.470.13-0.69-0.23-0.77-0.41-0.05-0.55-0.09-0.25-0.77-0.17-0.360.55-0.38-0.560.32-0.24-0.37
-0.5-0.040.1-0.56-0.14-0.18-0.17-0.970.25-0.580.20.130.210.030.21-0.550.20.13-0.51-0.170.250.04-0.12-0.020.2
-0.54-0.31-0.7-0.390.61-0.18-0.760.07-0.66-0.45-0.87-0.37-0.34-0.95-0.59-0.52-0.88-0.08-0.490.99-0.58-0.950.82-0.27-0.36
0.540.130.720.38-0.47-0.17-0.760.290.420.460.680.020.220.790.630.540.7-0.380.48-0.760.250.79-0.48-0.180.26
0.510.00.040.520.13-0.970.070.29-0.270.57-0.16-0.17-0.020.050.010.57-0.16-0.280.450.05-0.30.030.03-0.12-0.22
0.4-0.020.140.41-0.690.25-0.660.42-0.270.360.90.450.090.6-0.010.350.880.390.55-0.580.660.62-0.320.350.63
0.990.310.330.99-0.23-0.58-0.450.460.570.360.360.220.080.610.070.990.390.00.94-0.470.620.59-0.470.270.48
0.430.080.420.36-0.770.2-0.870.68-0.160.90.360.440.130.790.280.41.00.250.5-0.810.550.8-0.530.270.48
0.25-0.01-0.10.29-0.410.13-0.370.02-0.170.450.220.440.030.4-0.120.210.480.450.26-0.360.420.38-0.220.530.46
0.16-0.110.340.01-0.050.21-0.340.22-0.020.090.080.130.030.320.540.150.14-0.310.01-0.380.110.31-0.31-0.20.11
0.690.340.690.56-0.550.03-0.950.790.050.60.610.790.40.320.530.680.810.010.64-0.960.661.0-0.830.30.47
0.20.190.85-0.07-0.090.21-0.590.630.01-0.010.070.28-0.120.540.530.20.31-0.61-0.1-0.670.070.5-0.59-0.460.05
1.00.340.440.96-0.25-0.55-0.520.540.570.350.990.40.210.150.680.20.43-0.080.9-0.560.610.65-0.540.210.47
0.460.090.450.39-0.770.2-0.880.7-0.160.880.391.00.480.140.810.310.430.20.51-0.830.580.82-0.550.240.53
-0.080.17-0.460.08-0.170.13-0.08-0.38-0.280.390.00.250.45-0.310.01-0.61-0.080.20.20.020.250.04-0.060.87-0.1
0.910.260.20.95-0.36-0.51-0.490.480.450.550.940.50.260.010.64-0.10.90.510.2-0.460.660.65-0.410.450.48
-0.58-0.34-0.77-0.410.55-0.170.99-0.760.05-0.58-0.47-0.81-0.36-0.38-0.96-0.67-0.56-0.830.02-0.46-0.59-0.940.86-0.19-0.4
0.660.360.340.65-0.380.25-0.580.25-0.30.660.620.550.420.110.660.070.610.580.250.66-0.590.65-0.560.430.77
0.660.330.660.54-0.560.04-0.950.790.030.620.590.80.380.311.00.50.650.820.040.65-0.940.65-0.810.330.45
-0.54-0.51-0.71-0.390.32-0.120.82-0.480.03-0.32-0.47-0.53-0.22-0.31-0.83-0.59-0.54-0.55-0.06-0.410.86-0.56-0.81-0.32-0.25
0.210.33-0.260.34-0.24-0.02-0.27-0.18-0.120.350.270.270.53-0.20.3-0.460.210.240.870.45-0.190.430.33-0.320.02
0.54-0.030.220.54-0.370.2-0.360.26-0.220.630.480.480.460.110.470.050.470.53-0.10.48-0.40.770.45-0.250.02
Click cells to compare fundamentals

Lipocine Account Relationship Matchups

Lipocine fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets19.7M25.4M52.5M37.5M23.0M29.7M
Other Current Liab449.3K1.7M1M1.1M1.2M1.5M
Total Current Liabilities5.0M6.6M5.6M1.7M2.6M3.4M
Total Stockholder Equity6.3M15.3M45.6M35.6M20.4M24.6M
Net Debt(2.6M)(13.6M)(639.7K)(3.1M)(4.8M)(5.0M)
Retained Earnings(151.1M)(172.0M)(172.7M)(183.4M)(199.8M)(189.8M)
Accounts Payable1.2M1.6M1.3M600.4K1.4M798.8K
Cash9.7M19.2M3.0M3.1M4.8M9.2M
Cash And Short Term Investments14.1M19.7M44.6M32.5M22.0M26.6M
Common Stock Total Equity2.2K3.8K7.0K8.8K10.2K10.7K
Common Stock Shares Outstanding1.5M3.3M5.1M88.9M5.3M9.4M
Liabilities And Stockholders Equity19.7M25.4M52.5M37.5M23.0M29.7M
Other Current Assets545.9K661.3K1.5M945.3K773.4K1.0M
Other Stockholder Equity157.4M187.4M218.2M219.1M220.1M147.6M
Total Liab13.4M10.0M6.9M1.9M2.6M5.1M
Total Current Assets19.6M25.3M46.4M34.1M22.9M28.8M
Accumulated Other Comprehensive Income(963.0)(38.0)(18.0K)(20.3K)7.3K7.6K
Common Stock3.8K7.0K8.8K8.9K8.9K9.3K
Property Plant Equipment19.0K3.6K7.2K131.6K118.4K124.4K
Net Tangible Assets6.3M15.3M45.6M35.6M41.0M27.0M
Retained Earnings Total Equity(138.1M)(151.1M)(172.0M)(172.7M)(155.4M)(163.2M)
Short Term Investments4.3M450.0K41.7M29.4M17.3M15.1M
Capital Surpluse147.5M157.4M187.4M218.3M251.0M143.4M
Property Plant And Equipment Net3.6K0.07.2K131.6K116.1K63.4K
Non Current Assets Total27.3K23.8K6.1M3.4M139.8K132.9K
Property Plant And Equipment Gross3.6K1.1M1.2M1.3M1.3M1.4M
Net Receivables16.5K391.0247.3K659.9K52.3K49.6K
Net Invested Capital13.4M20.9M47.9M35.6M20.4M27.8M
Net Working Capital14.7M18.7M40.8M32.5M20.2M25.5M
Short Long Term Debt Total7.1M5.6M2.3M17.2K15.4K14.7K
Capital Stock3.8K7.0K8.8K8.9K8.9K7.2K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Lipocine Stock analysis

When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
(0.54)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.37)
Return On Equity
(0.58)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.